Italian registry for head and neck cancers
Part of Cancer, Ear, nose & throat clinical trials.
This registry collects information from Italian hospitals about people with head and neck cancers. By joining, you help doctors better understand the disease and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with a head and neck cancer (excluding sarcoma or lymphoma).
- You are currently being treated or followed at a hospital that is part of this registry, and your care started in 2021 or later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at newly diagnosed head and neck cancer before any treatment begins. It will analyze your cancer's genes and other markers to understand how it develops and grows, which may help improve future care.
This study looks at how different treatments (surgery, radiation, or medication) affect survival, complications, and quality of life in people with head and neck cancer. It aims to understand which treatments work best and why.
This study collects information from people with lung cancer who are treated at a specific hospital in Italy. The goal is to better understand the disease and improve future care.
This study is a cancer registry that collects information from people with lymphoma, Hodgkin disease, or myeloma. It helps researchers understand these cancers better by using real-world patient data.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study builds a European database (registry) of adults with certain head and neck cancers to better understand how these cancers are diagnosed and treated over time. It may help future care by collecting real-world information, rather than testing a new medicine.
Hear when a new Head and Neck Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.